Conference of Research and Application of New Vaccines for Pandemic Influenza and Seasonal Influenza
On May 2018, The Conference of Research and Application of New Vaccines for Pandemic Influenza and Seasonal Influenza was held in Biomedical industrial Park of Central Plains Economic Zone. Over 200 experts, leaders and professional people from Chinese Preventive Medicine Association, Division of Infectious Diseases in Chinese Center for Disease Control and Prevention (China ACDC), Immunization Planning Institute of Henan Center for Disease Control and Prevention, Infectious Diseases Control and Prevention Institute of Henan Center for Disease Control and Prevention, Hualan Biological Bacterin Co., Ltd. and other units attended the meeting.
Domestic experts on influenza prevention and control were invited to lecture, reviewing, reflecting the epidemic tendency, prevention and control measures for Type A H7N9 (avian influenza) and seasonal influenza last winter and this spring. Innovative development strategy of vaccines for pandemic influenza and seasonal influenza in China was also discussed. The most serious epidemic situation in China in the past ten years occurred in the influenza season of 2017-2018. At present, the effect of trivalent influenza vaccine is poor, for which WHO strongly recommends the use of Quadrivalent Influenza Vaccine.
As the 100th anniversary of the Spanish Flu Outbreak, the convening of this conference is of great social significance to promote the industrialization of new vaccines for pandemic influenza and seasonal influenza; improve the vaccine supply system, promote the sustained and healthy development of the relevant vaccine industry; and ensure the health of people.
TAG:  Hualan Biological Bacterin, Quadrivalent Influenza Vaccine, Pandemic Influenza, Seasonal Influenza